SlideShare a Scribd company logo
EMERGENCY VACCINATION BENEFITS
ERADICATION OF HYPOTHETICAL
INTRODUCTIONS OF FMD INTO NEW ZEALAND
Zhidong Yu, Robert Sanson, Thomas Rawdon, Katie Owen, Katie
Hickey, Mary van Andel.
By Kylee Walker on behalf of:
Impact of FMD outbreak in New Zealand
• Never had a case of FMD so we know little about how an outbreak would behave in
the New Zealand setting
• Catastrophic for the country
– Market shutdown for animal and animal products
– Loss of $16.2bn over 8 years
– Damage in life style, reputation and many other factors
FMD response policy in New Zealand
• Readiness to response primarily relied on stamping-out
• New policy: considers vaccination as an adjunct tool from the start of an outbreak
Purpose of the study
• Verify benefits of vaccination with extended scenarios
• Understand the key factors affecting the effectiveness of vaccination
• Suggest a practical vaccination strategy based on resources available
• Identify new areas for future study
Study design (1)
• Output indicators:
- Infected Premises (IP) numbers
- Outbreak duration (days)
- Area size under control (AUC)
• Three introduction scenarios:
- Auckland, Taranaki and
Christchurch
• Two levels of stamping-out
efficacy (compliance rates):
- Standard Stamping Out vs
Reduced Stamping Out
• Two vaccination efficacy (herd
immunity) settings.
Study design (2)
• Multiple factors (strategies, start time, etc):
– Starting time: 11, 14, 16, 21, 28 days PD or 50 /100 IPs
– SV and PV with variable zone sizes
– Cattle-only (Taranaki Only)
• Impact of personnel resource
Suppressive
vaccination
Protective
vaccination
Effect of vaccination start time
IP Duration Area under control
Effect of vaccination strategy and zone size
IP Duration Area under control
Vaccine dose requirements
Effects of personnel resource on vaccination
y ~ (1/x) y ~ (1/x)
R2 = 86% R2 = 78%
Key findings summarised
• Prevented run-away epidemics and aided control
• More effective when used early
• More beneficial for larger outbreaks
• Better effect for larger vaccination zone
• Personnel and vaccine resources influenced outcomes
• Cattle-only vaccination promising
Key factors influencing vaccination effects
• Air transmission
• Incursion scenario (location and detection settings)
• Incursion detection time
• Vaccination start day
• Herd immunity setting
Conclusions
• Findings consistent with many early studies - vaccination could benefit disease
control in New Zealand
• 3-5 km PV starting from Day 11-16 recommended
Future studies
• Recommended further studies to support vaccination decision-making:
– cattle-only vaccination,
– personnel resource requirements, and
– early indicators for potential large outbreaks.
Acknowledgements
Andre van Halderen: Contribution in macro-economic modelling and general advice
for this study.

More Related Content

What's hot

Mahoney Panama Dpb July 2009 V2
Mahoney Panama Dpb July 2009 V2Mahoney Panama Dpb July 2009 V2
Mahoney Panama Dpb July 2009 V2gambelguy
 
Serosurveillance and the PCP–FMD
Serosurveillance and the PCP–FMDSerosurveillance and the PCP–FMD
Serosurveillance and the PCP–FMDILRI
 
Dr. Dane Goede - Update on Porcine Epidemic Diarrhea Virus Studies
Dr. Dane Goede - Update on Porcine Epidemic Diarrhea Virus StudiesDr. Dane Goede - Update on Porcine Epidemic Diarrhea Virus Studies
Dr. Dane Goede - Update on Porcine Epidemic Diarrhea Virus StudiesJohn Blue
 
CDC's National Lyme Disease Prevention Program
CDC's National Lyme Disease Prevention ProgramCDC's National Lyme Disease Prevention Program
CDC's National Lyme Disease Prevention ProgramFairfax County
 
Lyme disease town meeting dr. beard, cdcp
Lyme disease town meeting dr. beard, cdcpLyme disease town meeting dr. beard, cdcp
Lyme disease town meeting dr. beard, cdcpguestd0991da
 
Prof Kim Mulholland @ MRF's Meningitis & Septicaemia in Adults & Children
Prof Kim Mulholland @ MRF's Meningitis & Septicaemia in Adults & ChildrenProf Kim Mulholland @ MRF's Meningitis & Septicaemia in Adults & Children
Prof Kim Mulholland @ MRF's Meningitis & Septicaemia in Adults & ChildrenMeningitis Research Foundation
 
Introduction Of New Vaccines In The Public Market
Introduction Of New Vaccines In The Public MarketIntroduction Of New Vaccines In The Public Market
Introduction Of New Vaccines In The Public MarketStefano Malvolti
 
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)THL
 
OS16 - 1.4.a Encouraging the Use of Vaccination-To-Live as a Control Strate...
OS16 - 1.4.a   Encouraging the Use of Vaccination-To-Live as a Control Strate...OS16 - 1.4.a   Encouraging the Use of Vaccination-To-Live as a Control Strate...
OS16 - 1.4.a Encouraging the Use of Vaccination-To-Live as a Control Strate...EuFMD
 
Covid 19 vaccine and development stages
Covid 19 vaccine and development stagesCovid 19 vaccine and development stages
Covid 19 vaccine and development stagesVeeprho Laboratories
 
Bi regional je immunzation sri lanka
Bi regional je immunzation  sri lankaBi regional je immunzation  sri lanka
Bi regional je immunzation sri lankalankansikh
 

What's hot (20)

Mahoney Panama Dpb July 2009 V2
Mahoney Panama Dpb July 2009 V2Mahoney Panama Dpb July 2009 V2
Mahoney Panama Dpb July 2009 V2
 
Professor Muhamed-Kheir Taha
Professor Muhamed-Kheir TahaProfessor Muhamed-Kheir Taha
Professor Muhamed-Kheir Taha
 
Serosurveillance and the PCP–FMD
Serosurveillance and the PCP–FMDSerosurveillance and the PCP–FMD
Serosurveillance and the PCP–FMD
 
Dr. Dane Goede - Update on Porcine Epidemic Diarrhea Virus Studies
Dr. Dane Goede - Update on Porcine Epidemic Diarrhea Virus StudiesDr. Dane Goede - Update on Porcine Epidemic Diarrhea Virus Studies
Dr. Dane Goede - Update on Porcine Epidemic Diarrhea Virus Studies
 
Covid seminar
Covid seminarCovid seminar
Covid seminar
 
Mark Lipsitch: "Simulation and Deliberation to Prepare for Clinical Trials in...
Mark Lipsitch: "Simulation and Deliberation to Prepare for Clinical Trials in...Mark Lipsitch: "Simulation and Deliberation to Prepare for Clinical Trials in...
Mark Lipsitch: "Simulation and Deliberation to Prepare for Clinical Trials in...
 
CDC's National Lyme Disease Prevention Program
CDC's National Lyme Disease Prevention ProgramCDC's National Lyme Disease Prevention Program
CDC's National Lyme Disease Prevention Program
 
Lyme disease town meeting dr. beard, cdcp
Lyme disease town meeting dr. beard, cdcpLyme disease town meeting dr. beard, cdcp
Lyme disease town meeting dr. beard, cdcp
 
Dr Rodolfo villena
Dr Rodolfo villena  Dr Rodolfo villena
Dr Rodolfo villena
 
Professor Sir Andrew Pollard
Professor Sir Andrew PollardProfessor Sir Andrew Pollard
Professor Sir Andrew Pollard
 
Prof Kim Mulholland @ MRF's Meningitis & Septicaemia in Adults & Children
Prof Kim Mulholland @ MRF's Meningitis & Septicaemia in Adults & ChildrenProf Kim Mulholland @ MRF's Meningitis & Septicaemia in Adults & Children
Prof Kim Mulholland @ MRF's Meningitis & Septicaemia in Adults & Children
 
Introduction Of New Vaccines In The Public Market
Introduction Of New Vaccines In The Public MarketIntroduction Of New Vaccines In The Public Market
Introduction Of New Vaccines In The Public Market
 
Dr Lee hampton
Dr Lee hamptonDr Lee hampton
Dr Lee hampton
 
The WHO/WPPRO Preparedness Strategy for EIDs
The WHO/WPPRO Preparedness Strategy for EIDsThe WHO/WPPRO Preparedness Strategy for EIDs
The WHO/WPPRO Preparedness Strategy for EIDs
 
Measles Control and AEFI
Measles Control and AEFI Measles Control and AEFI
Measles Control and AEFI
 
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
 
OS16 - 1.4.a Encouraging the Use of Vaccination-To-Live as a Control Strate...
OS16 - 1.4.a   Encouraging the Use of Vaccination-To-Live as a Control Strate...OS16 - 1.4.a   Encouraging the Use of Vaccination-To-Live as a Control Strate...
OS16 - 1.4.a Encouraging the Use of Vaccination-To-Live as a Control Strate...
 
Covid 19 vaccine and development stages
Covid 19 vaccine and development stagesCovid 19 vaccine and development stages
Covid 19 vaccine and development stages
 
Bi regional je immunzation sri lanka
Bi regional je immunzation  sri lankaBi regional je immunzation  sri lanka
Bi regional je immunzation sri lanka
 
COVID-19 Vaccine Trials: Why we still need them?
COVID-19 Vaccine Trials: Why we still need them?COVID-19 Vaccine Trials: Why we still need them?
COVID-19 Vaccine Trials: Why we still need them?
 

Similar to OS16 - 1.4.e Emergency Vaccination Benefits Eradication of Hypothetical Introductions of FMD into New Zealand - Z. Yu

OS16 - 1.4.f A Process Modelling Approach to Estimate FMD Diagnostic Capaci...
OS16 - 1.4.f   A Process Modelling Approach to Estimate FMD Diagnostic Capaci...OS16 - 1.4.f   A Process Modelling Approach to Estimate FMD Diagnostic Capaci...
OS16 - 1.4.f A Process Modelling Approach to Estimate FMD Diagnostic Capaci...EuFMD
 
OS18 - 2.2 Evaluating Vaccination strategies to control FMD: A Country compar...
OS18 - 2.2 Evaluating Vaccination strategies to control FMD: A Country compar...OS18 - 2.2 Evaluating Vaccination strategies to control FMD: A Country compar...
OS18 - 2.2 Evaluating Vaccination strategies to control FMD: A Country compar...EuFMD
 
Evaluating vaccination strategies to control foot-and-mouth disease: A count...
Evaluating vaccination strategies to control foot-and-mouth disease:  A count...Evaluating vaccination strategies to control foot-and-mouth disease:  A count...
Evaluating vaccination strategies to control foot-and-mouth disease: A count...EuFMD
 
Fresh from the press: Updated best practices in Surgical Site Infection Preve...
Fresh from the press: Updated best practices in Surgical Site Infection Preve...Fresh from the press: Updated best practices in Surgical Site Infection Preve...
Fresh from the press: Updated best practices in Surgical Site Infection Preve...Canadian Patient Safety Institute
 
EuFMD_emergency vaccination_workshop_14_06_2022_part2
EuFMD_emergency vaccination_workshop_14_06_2022_part2EuFMD_emergency vaccination_workshop_14_06_2022_part2
EuFMD_emergency vaccination_workshop_14_06_2022_part2EuFMD
 
Dengue part 2- emerging public health problem
Dengue part 2- emerging public health problemDengue part 2- emerging public health problem
Dengue part 2- emerging public health problemDr Kaushik Narayan
 
Dr. Mike Roof - Current status - "State of the Union" - PRRS vaccine research
Dr. Mike Roof - Current status - "State of the Union" - PRRS vaccine researchDr. Mike Roof - Current status - "State of the Union" - PRRS vaccine research
Dr. Mike Roof - Current status - "State of the Union" - PRRS vaccine researchJohn Blue
 
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSUREHUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSUREJAYA PRAKASH VELUCHURI
 
Modelling FMD vaccine requirements for multi-country FMD outbreaks in Europe
Modelling FMD vaccine requirements for multi-country FMD outbreaks in EuropeModelling FMD vaccine requirements for multi-country FMD outbreaks in Europe
Modelling FMD vaccine requirements for multi-country FMD outbreaks in EuropeEuFMD
 
OS18 - 2.1 Modelling FMD vaccine requirements for multi-country FMD outbreak...
OS18 - 2.1  Modelling FMD vaccine requirements for multi-country FMD outbreak...OS18 - 2.1  Modelling FMD vaccine requirements for multi-country FMD outbreak...
OS18 - 2.1 Modelling FMD vaccine requirements for multi-country FMD outbreak...EuFMD
 
State of foot-and-mouth disease research
State of foot-and-mouth disease researchState of foot-and-mouth disease research
State of foot-and-mouth disease researchILRI
 
Use of evidence based practices to improve survival - edited.pptx
Use of evidence based practices to improve survival - edited.pptxUse of evidence based practices to improve survival - edited.pptx
Use of evidence based practices to improve survival - edited.pptxDr Tete
 
Overview of Study Designs.pdf
Overview of Study Designs.pdfOverview of Study Designs.pdf
Overview of Study Designs.pdfssuser504dda
 
Immunization summit rota 2010
Immunization summit rota 2010Immunization summit rota 2010
Immunization summit rota 2010lankansikh
 
Current challenges in pertussis prevention gaurav gupta - sept 2016
Current challenges in pertussis prevention   gaurav gupta - sept 2016Current challenges in pertussis prevention   gaurav gupta - sept 2016
Current challenges in pertussis prevention gaurav gupta - sept 2016Gaurav Gupta
 
Out break investigation of a zoonotic disease
Out break investigation of a zoonotic diseaseOut break investigation of a zoonotic disease
Out break investigation of a zoonotic diseaseMdSalauddin20
 

Similar to OS16 - 1.4.e Emergency Vaccination Benefits Eradication of Hypothetical Introductions of FMD into New Zealand - Z. Yu (20)

OS16 - 1.4.f A Process Modelling Approach to Estimate FMD Diagnostic Capaci...
OS16 - 1.4.f   A Process Modelling Approach to Estimate FMD Diagnostic Capaci...OS16 - 1.4.f   A Process Modelling Approach to Estimate FMD Diagnostic Capaci...
OS16 - 1.4.f A Process Modelling Approach to Estimate FMD Diagnostic Capaci...
 
OS18 - 2.2 Evaluating Vaccination strategies to control FMD: A Country compar...
OS18 - 2.2 Evaluating Vaccination strategies to control FMD: A Country compar...OS18 - 2.2 Evaluating Vaccination strategies to control FMD: A Country compar...
OS18 - 2.2 Evaluating Vaccination strategies to control FMD: A Country compar...
 
Evaluating vaccination strategies to control foot-and-mouth disease: A count...
Evaluating vaccination strategies to control foot-and-mouth disease:  A count...Evaluating vaccination strategies to control foot-and-mouth disease:  A count...
Evaluating vaccination strategies to control foot-and-mouth disease: A count...
 
Fresh from the press: Updated best practices in Surgical Site Infection Preve...
Fresh from the press: Updated best practices in Surgical Site Infection Preve...Fresh from the press: Updated best practices in Surgical Site Infection Preve...
Fresh from the press: Updated best practices in Surgical Site Infection Preve...
 
EuFMD_emergency vaccination_workshop_14_06_2022_part2
EuFMD_emergency vaccination_workshop_14_06_2022_part2EuFMD_emergency vaccination_workshop_14_06_2022_part2
EuFMD_emergency vaccination_workshop_14_06_2022_part2
 
Dengue part 2- emerging public health problem
Dengue part 2- emerging public health problemDengue part 2- emerging public health problem
Dengue part 2- emerging public health problem
 
Dr. Mike Roof - Current status - "State of the Union" - PRRS vaccine research
Dr. Mike Roof - Current status - "State of the Union" - PRRS vaccine researchDr. Mike Roof - Current status - "State of the Union" - PRRS vaccine research
Dr. Mike Roof - Current status - "State of the Union" - PRRS vaccine research
 
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSUREHUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
 
Vaccine safety
Vaccine safetyVaccine safety
Vaccine safety
 
2015 pharmacoepidemiological study of menactra by meriem taib - Professor P...
2015   pharmacoepidemiological study of menactra by meriem taib - Professor P...2015   pharmacoepidemiological study of menactra by meriem taib - Professor P...
2015 pharmacoepidemiological study of menactra by meriem taib - Professor P...
 
Modelling FMD vaccine requirements for multi-country FMD outbreaks in Europe
Modelling FMD vaccine requirements for multi-country FMD outbreaks in EuropeModelling FMD vaccine requirements for multi-country FMD outbreaks in Europe
Modelling FMD vaccine requirements for multi-country FMD outbreaks in Europe
 
OS18 - 2.1 Modelling FMD vaccine requirements for multi-country FMD outbreak...
OS18 - 2.1  Modelling FMD vaccine requirements for multi-country FMD outbreak...OS18 - 2.1  Modelling FMD vaccine requirements for multi-country FMD outbreak...
OS18 - 2.1 Modelling FMD vaccine requirements for multi-country FMD outbreak...
 
State of foot-and-mouth disease research
State of foot-and-mouth disease researchState of foot-and-mouth disease research
State of foot-and-mouth disease research
 
Use of evidence based practices to improve survival - edited.pptx
Use of evidence based practices to improve survival - edited.pptxUse of evidence based practices to improve survival - edited.pptx
Use of evidence based practices to improve survival - edited.pptx
 
Overview of Study Designs.pdf
Overview of Study Designs.pdfOverview of Study Designs.pdf
Overview of Study Designs.pdf
 
Immunization summit rota 2010
Immunization summit rota 2010Immunization summit rota 2010
Immunization summit rota 2010
 
Current challenges in pertussis prevention gaurav gupta - sept 2016
Current challenges in pertussis prevention   gaurav gupta - sept 2016Current challenges in pertussis prevention   gaurav gupta - sept 2016
Current challenges in pertussis prevention gaurav gupta - sept 2016
 
Vap prevention 2014 ppt
Vap prevention 2014 pptVap prevention 2014 ppt
Vap prevention 2014 ppt
 
Out break investigation of a zoonotic disease
Out break investigation of a zoonotic diseaseOut break investigation of a zoonotic disease
Out break investigation of a zoonotic disease
 
Health, Climate and Innovation
Health, Climate and InnovationHealth, Climate and Innovation
Health, Climate and Innovation
 

More from EuFMD

VADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdfVADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdfEuFMD
 
Vaccine delivery and demand workshop
Vaccine delivery and demand workshopVaccine delivery and demand workshop
Vaccine delivery and demand workshopEuFMD
 
Emergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdfEmergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdfEuFMD
 
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...EuFMD
 
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...EuFMD
 
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...EuFMD
 
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...EuFMD
 
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...EuFMD
 
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...EuFMD
 
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...EuFMD
 
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...EuFMD
 
LSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in AlbaniaLSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in AlbaniaEuFMD
 
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...EuFMD
 
LSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong KongLSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong KongEuFMD
 
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...EuFMD
 
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...EuFMD
 
LSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from IndiaLSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from IndiaEuFMD
 
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...EuFMD
 
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...EuFMD
 
LSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin diseaseLSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin diseaseEuFMD
 

More from EuFMD (20)

VADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdfVADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdf
 
Vaccine delivery and demand workshop
Vaccine delivery and demand workshopVaccine delivery and demand workshop
Vaccine delivery and demand workshop
 
Emergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdfEmergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdf
 
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
 
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
 
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
 
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
 
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
 
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
 
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
 
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
 
LSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in AlbaniaLSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in Albania
 
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
 
LSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong KongLSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong Kong
 
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
 
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
 
LSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from IndiaLSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from India
 
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
 
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
 
LSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin diseaseLSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
 

Recently uploaded

FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsMichel Dumontier
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxAlguinaldoKong
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGAADYARAJPANDEY1
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
 
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdfPests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdfPirithiRaju
 
A Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on EarthA Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on EarthSérgio Sacani
 
FAIRSpectra - Towards a common data file format for SIMS images
FAIRSpectra - Towards a common data file format for SIMS imagesFAIRSpectra - Towards a common data file format for SIMS images
FAIRSpectra - Towards a common data file format for SIMS imagesAlex Henderson
 
Predicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdfPredicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdfbinhminhvu04
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard Gill
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...Health Advances
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rockskumarmathi863
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...NathanBaughman3
 
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiologyBLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiologyNoelManyise1
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
 
INSIGHT Partner Profile: Tampere University
INSIGHT Partner Profile: Tampere UniversityINSIGHT Partner Profile: Tampere University
INSIGHT Partner Profile: Tampere UniversitySteffi Friedrichs
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxmuralinath2
 
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptxGLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptxSultanMuhammadGhauri
 
Shuaib Y-basedComprehensive mahmudj.pptx
Shuaib Y-basedComprehensive mahmudj.pptxShuaib Y-basedComprehensive mahmudj.pptx
Shuaib Y-basedComprehensive mahmudj.pptxMdAbuRayhan16
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSELF-EXPLANATORY
 

Recently uploaded (20)

FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdfPests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
 
A Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on EarthA Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on Earth
 
FAIRSpectra - Towards a common data file format for SIMS images
FAIRSpectra - Towards a common data file format for SIMS imagesFAIRSpectra - Towards a common data file format for SIMS images
FAIRSpectra - Towards a common data file format for SIMS images
 
Predicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdfPredicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdf
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiologyBLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
INSIGHT Partner Profile: Tampere University
INSIGHT Partner Profile: Tampere UniversityINSIGHT Partner Profile: Tampere University
INSIGHT Partner Profile: Tampere University
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptxGLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
 
Shuaib Y-basedComprehensive mahmudj.pptx
Shuaib Y-basedComprehensive mahmudj.pptxShuaib Y-basedComprehensive mahmudj.pptx
Shuaib Y-basedComprehensive mahmudj.pptx
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
 

OS16 - 1.4.e Emergency Vaccination Benefits Eradication of Hypothetical Introductions of FMD into New Zealand - Z. Yu

  • 1. EMERGENCY VACCINATION BENEFITS ERADICATION OF HYPOTHETICAL INTRODUCTIONS OF FMD INTO NEW ZEALAND Zhidong Yu, Robert Sanson, Thomas Rawdon, Katie Owen, Katie Hickey, Mary van Andel. By Kylee Walker on behalf of:
  • 2. Impact of FMD outbreak in New Zealand • Never had a case of FMD so we know little about how an outbreak would behave in the New Zealand setting • Catastrophic for the country – Market shutdown for animal and animal products – Loss of $16.2bn over 8 years – Damage in life style, reputation and many other factors
  • 3. FMD response policy in New Zealand • Readiness to response primarily relied on stamping-out • New policy: considers vaccination as an adjunct tool from the start of an outbreak
  • 4. Purpose of the study • Verify benefits of vaccination with extended scenarios • Understand the key factors affecting the effectiveness of vaccination • Suggest a practical vaccination strategy based on resources available • Identify new areas for future study
  • 5. Study design (1) • Output indicators: - Infected Premises (IP) numbers - Outbreak duration (days) - Area size under control (AUC) • Three introduction scenarios: - Auckland, Taranaki and Christchurch • Two levels of stamping-out efficacy (compliance rates): - Standard Stamping Out vs Reduced Stamping Out • Two vaccination efficacy (herd immunity) settings.
  • 6. Study design (2) • Multiple factors (strategies, start time, etc): – Starting time: 11, 14, 16, 21, 28 days PD or 50 /100 IPs – SV and PV with variable zone sizes – Cattle-only (Taranaki Only) • Impact of personnel resource Suppressive vaccination Protective vaccination
  • 7. Effect of vaccination start time IP Duration Area under control
  • 8. Effect of vaccination strategy and zone size IP Duration Area under control
  • 10. Effects of personnel resource on vaccination y ~ (1/x) y ~ (1/x) R2 = 86% R2 = 78%
  • 11. Key findings summarised • Prevented run-away epidemics and aided control • More effective when used early • More beneficial for larger outbreaks • Better effect for larger vaccination zone • Personnel and vaccine resources influenced outcomes • Cattle-only vaccination promising
  • 12. Key factors influencing vaccination effects • Air transmission • Incursion scenario (location and detection settings) • Incursion detection time • Vaccination start day • Herd immunity setting
  • 13. Conclusions • Findings consistent with many early studies - vaccination could benefit disease control in New Zealand • 3-5 km PV starting from Day 11-16 recommended
  • 14. Future studies • Recommended further studies to support vaccination decision-making: – cattle-only vaccination, – personnel resource requirements, and – early indicators for potential large outbreaks.
  • 15. Acknowledgements Andre van Halderen: Contribution in macro-economic modelling and general advice for this study.